Skip to main content

Animations

MJFF Publications

6301 - 6310 of 8620 Results
Title
Year
  • Year
  • 2019
  • 2022
  • 2013
  • 2016
  • 2021
  • 2025
  • 2022
  • 2015
  • 2025
  • 2017
  • Summary Details
    RESTRICTED
    Title: Revisiting the non-Gaucher-GBA-E326K carrier state: Is it sufficient to increase Parkinson's disease risk?
    Journal Name: Molecular Genetics and Metabolism
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.ymgme.2019.10.001
    Best OA location URL:
    Citation Count: 37
  • Summary Details
    OPEN
    Title: SHIP164 is a chorein motif lipid transfer protein that controls endosome–Golgi membrane traffic
    Journal Name: Journal of Cell Biology
    Publisher: Rockefeller University Press
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1083/jcb.202111018
    Citation Count: 27
  • Summary Details
    RESTRICTED
    Title: 5-Hydroxy-tryptophan for the treatment of l-DOPA-induced dyskinesia in the rat Parkinson's disease model
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2013.08.014
    Best OA location URL:
    Citation Count: 52
  • Summary Details
    OPEN
    Title: Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPases
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.7554/elife.12813
    Citation Count: 925
  • Summary Details
    OPEN
    Title: Mutation in protein disulfide isomerase A3 causes neurodevelopmental defects by disturbing endoplasmic reticulum proteostasis
    Journal Name: The EMBO Journal
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.15252/embj.2020105531
    Citation Count: 23
  • Summary Details
    RESTRICTED
    Title: Plasma Phosphorylated Tau181 as a Biomarker for Alzheimer's Disease Co‐Pathology in Lewy Body Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.30238
    Best OA location URL:
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Site-Specific Phospho-Tau Aggregation-Based Biomarker Discovery for AD Diagnosis and Differentiation
    Journal Name: ACS Chemical Neuroscience
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1021/acschemneuro.2c00342
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Intact working memory in non‐manifesting LRRK2 carriers – an fMRI study
    Journal Name: European Journal of Neuroscience
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/ejn.13120
    Citation Count: 20
  • Summary Details
    OPEN
    Title: Use of Robust Norming to Create a Sensitive Cognitive Summary Score in De Novo Parkinson's Disease: An Illustrative Example
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.30111
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Differential Aging Analysis in Human Cerebral Cortex Identifies Variants in TMEM106B and GRN that Regulate Aging Phenotypes
    Journal Name: Cell Systems
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.cels.2017.02.009
    Citation Count: 113
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.